4d Molecular Therapeutics, Inc. · NASDAQ:FDMT
Novo Holdings A/S reported a 6.80% stake in 4d Molecular Therapeutics, Inc. (Schedule 13G)
Event Oct 13, 2025 · Filed Oct 20, 2025
Novo Holdings A/S reported a 6.80% stake in 4d Molecular Therapeutics, Inc., 3,175,000 shares, as a passive investor on Oct 13, 2025. Filed Oct 20, 2025 (Schedule 13G).
- Stake
- 6.80%
- Shares
- 3,175,000
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Novo Holdings A/S | 6.80% | 3,175,000 |
Source
Related
- 4d Molecular Therapeutics, Inc.
- Novo Holdings A/S
- 4d Molecular Therapeutics, Inc. shareholders
- Schedule 13G/A · Novo Holdings A/S · Feb 17, 2026
- Form 4 · Bizily Scott · Oct 20, 2026
- Form 4 · Kirn David · Oct 7, 2026
- Form 4 · Bizily Scott · Sep 22, 2026
- Form 4 · Kirn David · Sep 16, 2026
- Form 4 · Bizily Scott · Sep 3, 2026